Iterum Therapeutics News and Activities

Iterum Therapeutics is a company listed under the stock ticker ITRM (US).

Acquisition, funding and merger involving Iterum Therapeutics.

• Iterum Therapeutics has filed for bankruptcy protection  (posted on April 22 2026).

View the org chart displaying its 8 main executives

Most searched biographies at Iterum Therapeutics

• Corey Fishman, Chief Executive Officer and Director
• Michael Dunne, Director
• David Kelly, Director

Popular executive movements at Iterum Therapeutics

• Tom Loughman, Senior Vice President, Technical Operations, has left the company  (posted on April 23 2026).
• Beth Hecht, Director, has left the company  (posted on April 23 2026).
• Judith Matthews, Chief Financial Officer, has left the company  (posted on April 17 2026).

Create your alert
to follow the executive moves at Iterum Therapeutics.

Iterum Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Iterum Therapeutics

• Iterum Therapeutics Announces Filing of Winding Up Petition
• Iterum Therapeutics Provides Business Update
• Iterum Therapeutics Provides Business Update
• Iterum Therapeutics Provides Business Update
• Iterum Therapeutics Provides Business Update
• Press Releases
• Iterum Therapeutics Provides Business Update
• Iterum Therapeutics Reports Third Quarter 2025 Financial Results
• Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
• Iterum Therapeutics to Present Data at IDWeek 2025
• View more press releases Close

Social media about Iterum Therapeutics

• Iterum Therapeutics on Wikipedia, Google News & Yahoo Finance
• Iterum Therapeutics on LinkedIn, X (Twitter) & YouTube